Predictors of treatment response in chronic spontaneous urticaria

JS Fok, P Kolkhir, MK Church, M Maurer - Allergy, 2021 - Wiley Online Library
The current therapeutic algorithm for chronic spontaneous urticaria (CSU), endorsed by the
international guideline, entails treatment escalation from second‐generation H1 …

Chronic urticaria: advances in understanding of the disease and clinical management

L He, W Yi, X Huang, H Long, Q Lu - Clinical reviews in allergy & …, 2021 - Springer
Chronic urticaria (CU) is a common skin condition characterized by the recurrence of
wheals, with or without angioedema, which lasts for at least 6 weeks. Owing to its pruritus …

Autoimmune chronic spontaneous urticaria detection with IgG anti-TPO and total IgE

P Kolkhir, E Kovalkova, A Chernov… - The Journal of Allergy …, 2021 - Elsevier
Background Autoimmune chronic spontaneous urticaria (aiCSU) comes with high disease
activity and poor response to treatment. Recently, elevated levels of IgG anti–thyroid …

[HTML][HTML] Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria

P Kolkhir, S Altrichter, R Asero, A Daschner… - Allergy, Asthma & …, 2021 - ncbi.nlm.nih.gov
Purpose Patients with chronic spontaneous urticaria (CSU) have an increased risk for
comorbid autoimmune diseases. In this retrospective multicenter study of CSU patients, we …

Biomarkers for monitoring treatment response of omalizumab in patients with chronic urticaria

NH Pedersen, JA Sørensen, MN Ghazanfar… - International Journal of …, 2023 - mdpi.com
Chronic urticaria (CU) is a debilitating skin disease affecting around 1% of the population.
CU can be subdivided into chronic spontaneous urticaria (CSU) and chronic inducible …

Autoimmune chronic spontaneous urticaria

P Kolkhir, M Muñoz, R Asero, M Ferrer… - Journal of Allergy and …, 2022 - Elsevier
Chronic spontaneous urticaria (CSU) is a debilitating mast cell–driven disease
characterized by recurrent wheals and/or angioedema. Substantial progress has been made …

Thyroid autoimmunity in CSU: a potential marker of omalizumab response?

R Asero, SM Ferrucci, P Calzari, D Consonni… - International Journal of …, 2023 - mdpi.com
The response of severe chronic spontaneous urticaria (CSU) to omalizumab largely
depends on the autoimmune or autoallergic endotype of the disease. Whether thyroid …

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status

TB Casale, AM Gimenez-Arnau, JA Bernstein… - Dermatology and …, 2023 - Springer
Chronic spontaneous urticaria (CSU) is a debilitating inflammatory disorder of the skin,
characterized by a fluctuating natural history, a complex mechanism of action, and a …

Chronic spontaneous urticaria: new evidences on the role of autoimmunity

YK Xiang, S Guloglu, D Elieh-Ali-Komi… - Current opinion in …, 2023 - journals.lww.com
Further investigations are needed to explore new autoallergens and autoantibodies in CSU,
establishing their connection to the development of autoimmunity. The efficacy of novel …

Biomarkers of chronic spontaneous urticaria and their clinical implications

R Asero, M Cugno - Expert review of clinical immunology, 2021 - Taylor & Francis
Introduction: Chronic spontaneous urticaria (CSU) is a frequent disorder in which activation
of effector cells and histamine release can be induced via several distinct pathogenetic …